Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features
Authors
Keywords
-
Journal
Arthritis & Rheumatology
Volume 69, Issue 3, Pages 630-642
Publisher
Wiley
Online
2016-11-19
DOI
10.1002/art.40004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification
- (2016) Melissa E Munroe et al. ANNALS OF THE RHEUMATIC DISEASES
- Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies
- (2016) Rufei Lu et al. JOURNAL OF AUTOIMMUNITY
- We Need Better Classification and Terminology for “People at High Risk of or in the Process of Developing Lupus”
- (2015) Karen H. Costenbader et al. ARTHRITIS CARE & RESEARCH
- Familial Aggregation of Systemic Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected Families
- (2015) Chang-Fu Kuo et al. JAMA Internal Medicine
- Systemic lupus erythematosus: a therapeutic challenge for the XXI century
- (2014) Manuel F. Ugarte-Gil et al. CLINICAL RHEUMATOLOGY
- Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controls
- (2014) KA Young et al. LUPUS
- Preclinical Systemic Lupus Erythematosus
- (2014) Julie M. Robertson et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Environmental Influences on Systemic Lupus Erythematosus Expression
- (2014) Diane L. Kamen RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Proinflammatory Adaptive Cytokine and Shed Tumor Necrosis Factor Receptor Levels Are Elevated Preceding Systemic Lupus Erythematosus Disease Flare
- (2014) Melissa E. Munroe et al. Arthritis & Rheumatology
- Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals
- (2013) Natalie Nokoff et al. Annals of the New York Academy of Sciences
- Belimumab Therapy in Systemic Lupus Erythematosus
- (2013) Moncef Zouali et al. BIODRUGS
- Autoantibodies and SLE—the threshold for disease
- (2013) Nancy J. Olsen et al. Nature Reviews Rheumatology
- Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleys
- (2013) Aikaterini Thanou et al. Nature Reviews Rheumatology
- Recent insights into the genetic basis of systemic lupus erythematosus
- (2012) Ornella Josephine Rullo et al. ANNALS OF THE RHEUMATIC DISEASES
- Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA)
- (2012) Jan M Hughes-Austin et al. ANNALS OF THE RHEUMATIC DISEASES
- Prevalence and sociodemographic correlates of antinuclear antibodies in the United States
- (2012) Minoru Satoh et al. ARTHRITIS AND RHEUMATISM
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
- (2012) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members
- (2012) Benjamin F. Bruner et al. ARTHRITIS AND RHEUMATISM
- The Humanistic and Economic Burden of Systemic Lupus Erythematosus
- (2012) Rachel Meacock et al. PHARMACOECONOMICS
- Compensatory T-Cell Regulation in Unaffected Relatives of SLE Patients, and Opposite IL-2/CD25-Mediated Effects Suggested by Coreferentiality Modeling
- (2012) Constantin Fesel et al. PLoS One
- Current and Future Immunomodulation Strategies to Restore Tolerance in Autoimmune Diseases
- (2012) J. A. Bluestone et al. Cold Spring Harbor Perspectives in Biology
- Healthcare Utilization and Costs of Systemic Lupus Erythematosus in Medicaid
- (2012) Hong J. Kan et al. Biomed Research International
- Recent advances in the genetics of systemic lupus erythematosus
- (2011) Donna L Thibault Flesher et al. Expert Review of Clinical Immunology
- Regulatory T-Cell-Associated Cytokines in Systemic Lupus Erythematosus
- (2011) Akiko Okamoto et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Systemic Lupus Erythematosus
- (2011) George C. Tsokos NEW ENGLAND JOURNAL OF MEDICINE
- Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort
- (2011) M. B. Urowitz et al. ARTHRITIS CARE & RESEARCH
- Signaling of c-kit in dendritic cells influences adaptive immunity
- (2010) Prabir Ray et al. Annals of the New York Academy of Sciences
- The Lupus Family Registry and Repository
- (2010) A. Rasmussen et al. RHEUMATOLOGY
- Type I Interferon Modulates Monocyte Recruitment and Maturation in Chronic Inflammation
- (2009) Pui Y. Lee et al. AMERICAN JOURNAL OF PATHOLOGY
- Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-α–producing antigen-presenting cells
- (2008) Bing Yan et al. ARTHRITIS AND RHEUMATISM
- Autoantibody prevalence and lupus characteristics in a unique African American population
- (2008) Diane L. Kamen et al. ARTHRITIS AND RHEUMATISM
- Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance
- (2008) MI Vargas-Rojas et al. LUPUS
- Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils
- (2007) Patrizia Scapini et al. IMMUNOLOGY LETTERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started